)
)
Personalis Investor Relations Material
Latest events
Q3 2024
Personalis
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Personalis Inc
Access all reports
Segment Data
Access more data
Revenue by
Customer type
Pharma tests and services
Enterprise sales
Population sequencing
Other
Expenses by
Financials
Personalis Cancer Genome Tests allow physicians to classify patients' tumors based on shared genomic changes and match them with therapies known to be effective for those alterations, such as targeted therapies, immunotherapies, or clinical trials. Its software solutions include ACE Clinical that provides clinical researchers with data-driven insights into biomarkers and biologic drug mechanisms; ACE Biology that interprets human genome information to allow researchers to gain insight into potential oncology drug targets and underlying mechanisms of drug resistance; and Product Management platform that allows customers to order personalized tests. The company was formerly known as Illumina TRUseq Custom Amplicon and changed its name to Personalis, Inc. in May 2013. Personalis, Inc. was founded in 2012 and is headquartered in Menlo Park, California.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PSNL
Country
🇺🇸 United States